He has published more than 25 papers and is an inventor of over 15 issued/pending patents. Some of his nanomedicine research work has formed the foundation for the launch of two biotechnology companies?Selecta Biosciences and Koan Therapeutics; and resulted in the clinical trial of a first-in-class synthetic nanoparticle vaccine for smoking cessation. He has also received many awards, including the K99/R00 Award from National Cancer Institute and Young Investigator Award from Prostate Cancer Foundation.